Search for Clinical Trial Results
Anemia, Refractory, with Excess of Blasts - 175 Studies Found
Status | Study |
Completed |
Study Name: Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy Condition:
Interventions: |
Terminated |
Study Name: A Randomized Study of Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia. Condition: Acute Myeloid Leukemia Date: 2006-08-11 Interventions:
|
Recruiting |
Study Name: Ibrutinib and Azacitidine for Treatment of Higher Risk Myelodysplastic Syndrome Condition:
|
Active, not recruiting |
Study Name: DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Condition:
|
Completed |
Study Name: Thalidomide in Treating Patients With Myelodysplastic Syndrome Condition:
|
Completed |
Study Name: Tipifarnib in Treating Patients With Myelodysplastic Syndromes Condition:
|
Completed |
Study Name: Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome Condition:
Interventions: |
Completed |
Study Name: PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome Condition:
Interventions: Drug: bortezomib Given IV Other Names: |
Recruiting |
Study Name: Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies Condition:
|
Completed |
Study Name: Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies Condition:
Interventions: |